Cargando…

Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study

OBJECTIVE: To evaluate the prevalence of infections, prevalence of hospitalisation due to infections, the vaccination status and perceived screening of infections prior to the start of biologic disease modifying antirheumatic drugs (bDMARDs) of a patient cohort with chronic inflammatory rheumatic di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiltz, Uta, Celik, Aylin, Tsiami, Styliani, Buehring, Bjoern, Baraliakos, Xenofon, Andreica, Ioana, Kiefer, David, Braun, Juergen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039255/ https://www.ncbi.nlm.nih.gov/pubmed/33832974 http://dx.doi.org/10.1136/rmdopen-2020-001499

Ejemplares similares

Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care
por: Redeker, Imke, et al.
Publicado: (2023)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study
por: Andreica, Ioana, et al.
Publicado: (2023)

Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review
por: Neusser, Silke, et al.
Publicado: (2022)

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
por: Roman, Iulia, et al.
Publicado: (2022)

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
por: Andreica, Ioana, et al.
Publicado: (2022)

Wie gut sind Patienten mit entzündlich rheumatischen Erkrankungen gegen Masern geschützt?
por: Kiltz, U., et al.
Publicado: (2020)

High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis
por: Krekeler, Martin, et al.
Publicado: (2022)

Pearls and Pitfalls in Diagnosing Non-Radiographic Axial Spondyloarthritis
por: Tsiami, Styliani, et al.
Publicado: (2022)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
por: Braun, Jürgen, et al.
Publicado: (2022)

New developments in ankylosing spondylitis—status in 2021
por: Klavdianou, Kalliopi, et al.
Publicado: (2021)

Erratum to: New developments in Ankylosing spondylitis – Status in 2021
por: Klavdianou, Kalliopi, et al.
Publicado: (2022)

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
por: Braun, Jürgen, et al.
Publicado: (2021)

Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID‐19) pandemic: A case series
por: Baraliakos, Xenofon, et al.
Publicado: (2022)

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment
por: Papagoras, Charalampos, et al.
Publicado: (2022)

Dopamine receptor 1 expressing B cells exert a proinflammatory role in female patients with rheumatoid arthritis
por: Wieber, Karolin, et al.
Publicado: (2022)

Wie viele Patienten mit entzündlich rheumatischen Erkrankungen haben die technischen Voraussetzungen für Videosprechstunden und sind bereit, fachärztliche Visiten so durchzuführen?
por: Baraliakos, X., et al.
Publicado: (2021)

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1
por: Braun, Jürgen, et al.
Publicado: (2021)

Do patients with ankylosing spondylitis adapt to their disease? Evidence from a ‘then-test’ in patients treated with TNF inhibitors
por: Essers, Ivette, et al.
Publicado: (2015)

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry
por: Marques, Claudia Diniz Lopes, et al.
Publicado: (2021)

Chronic but not inflammatory changes at the Achilles’ tendon differentiate patients with peripheral spondyloarthritis from other diagnoses – Results from a prospective clinical trial
por: Baraliakos, Xenofon, et al.
Publicado: (2017)

Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study
por: Kiltz, Uta, et al.
Publicado: (2017)

Functional MR imaging beyond structure and inflammation—radiographic axial spondyloarthritis is associated with proteoglycan depletion of the lumbar spine
por: Abrar, Daniel B., et al.
Publicado: (2020)

„Verankerung“ von Klassifikationskriterien für axiale Spondyloarthritis – wie weit ist gut für die Diagnosestellung?
por: Braun, J., et al.
Publicado: (2020)

Modulation of Dopamine Receptors on Osteoblasts as a Possible Therapeutic Strategy for Inducing Bone Formation in Arthritis
por: Schwendich, Elena, et al.
Publicado: (2022)

Exercise, infection and rheumatic diseases: what do we know?
por: Calabrese, Leonard, et al.
Publicado: (2021)

Evaluation des Trabecular Bone Score (TBS) in der täglichen Praxis bei Patienten mit entzündlich rheumatischen und nichtentzündlichen Erkrankungen: Korrelation mit konventioneller Knochendichtemessung und Prävalenz von Wirbelkörperfrakturen
por: Buehring, B., et al.
Publicado: (2020)

Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
por: Santos, Cristiana Sieiro, et al.
Publicado: (2021)

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021)

The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
por: Baraliakos, Xenofon, et al.
Publicado: (2008)

Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases
por: Waldecker-Gall, Sabina, et al.
Publicado: (2023)

Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
por: Sieiro Santos, Cristiana, et al.
Publicado: (2022)

Addressing the spread of health-related misinformation on social networks: an opinion article
por: Polyzou, Maria, et al.
Publicado: (2023)

Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study
por: Álvaro Gracia, Jose María, et al.
Publicado: (2021)

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Leitfaden „Geschlechtergerechte Sprache in der DGRh e. V.“
por: Haase, Isabell, et al.
Publicado: (2022)

Maternal and neonatal antibody levels on pertussis vaccination in pregnant women on immune-modulating therapy for rheumatic disease
por: Ghalandari, Nafise, et al.
Publicado: (2023)

Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients
por: Overheu, Oliver, et al.
Publicado: (2022)

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
por: Baraliakos, Xenofon, et al.
Publicado: (2005)

Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up
por: Naovarat, Benjamin Sornrung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ns4os682o1bdga0iaacr7t0ijn